hematologic malignancies Genetron Health Licenses ImmuQuad Technology for Blood Cancer Testing Under the agreement, Genetron gains exclusive rights to develop and commercialize minimal residual disease assays using ImmuQuad's immunogenomics technology. Germline Variants Contribute to Risk of Developing Aging-Related Clonal Hematopoiesis Researchers identified one germline variant near TET2 that appears to be specific to individuals of African ancestry. MSK Clonal Hematopoiesis Clinic Aims to Drive New Strategies for Cancer Risk Assessment, Prevention Premium The program is in its third year monitoring individuals with these mutations to try to detect disease early, understand their risk, and develop preventive treatments. Study Spells Out Immune, Genomic, Epigenomic Interactions in Hematological Malignancies Transcriptomic and multi-omic data spanning more than 10,000 samples helped map "immunogenomic" interactions that may inform treatment outcomes and targets. BioSkryb, St. Jude Expand Licensing Deal for Dx Applications of Single-Cell Tech BioSkryb will now have an exclusive global license for clinical applications of primary template directed amplification technology. Sep 3, 2019 Molecular Aging Initiative to Profile Clonal Hematopoiesis Consequences in Patient Populations Premium May 30, 2019 PreCancer Atlas Attempts to Push Precision Medicine to Early-Stage Disease Premium Apr 24, 2019 Multiple Myeloma Sequences Reveal Prognostic Immunoglobulin Translocation Mar 12, 2019 First Veterans Affairs MDx Lab Launches NGS-Based Cancer Panel; Others to Follow Premium Feb 25, 2019 Bionano Customers Explore Diagnostic Applications of Genome Maps in Cancer, Genetic Disorders Premium Dec 3, 2018 NGeneBio Raises $11M Oct 11, 2018 Multiple Myeloma Subtypes Linked to Patients' African Ancestry Jul 11, 2018 Mosaic Chromosomal Alterations in Blood Help Explain Origins of Clonal Hematopoiesis Apr 26, 2018 CGI Maps Plan for Turnaround Amid Challenges Premium Jan 25, 2018 Building on BRCA Test Launch, NGeneBio Rolls Out NGS Panels for Solid Tumors, Hematological Cancers Premium Jan 10, 2018 Amgen Finland, BC Platforms Partner to Link Genomic Data, EMRs in Disease Studies Premium Aug 31, 2017 Tempus, UC Davis Cancer Center Form Personalized Medicine Alliance Aug 22, 2017 Mass General, CRISPR Therapeutics to Develop Cancer Therapies Jul 7, 2017 Bionano Genomics, Genoptix Aim to Develop Hematology Diagnostics to Replace Karyotyping, FISH Assays Premium Jun 28, 2017 Bionano, Genoptix Sign Codevelopment Agreement for Hematology Diagnostics May 17, 2017 Mayo Clinic Lab Launches Clinical Mate-Pair Sequencing Test for Balanced Rearrangements Premium Jan 31, 2017 Invivoscribe, Thermo Fisher to Develop FLT3 Mutation, Clonality Assay Kits Mar 31, 2016 Invivoscribe Aiming to Bring CDx, MRD Tests for Hematological Cancers Through FDA Clearance Premium Mar 25, 2016 Foundation Medicine Shares Results From Validation of FoundationOne Heme in New Study Jul 8, 2015 Mayo Researchers Develop MP-seq Test to Detect Rearrangements in Cancers, Genetic Disease Premium Load More Breaking News BTIG Initiates Coverage of Berkeley Lights With Buy Rating Quest Diagnostics to Offer Biocept's Target Selector NGS Lung Cancer Test Novacyt 2020 Revenues Surge on Strong Demand for SARS-CoV-2 Testing Products Leidos Wins CDC Bioinformatics Contract Worth up to $13M Thermo Fisher Scientific Next-Generation SARS-CoV-2 PCR Test Nabs CE-IVD Mark Cytosine Base Editor Enables Genome-Wide Genetic Function Screening The Scan DTC Regulation Proposals A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports. PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more. Renewed Gain-of-Function Worries The New York Times writes that the pandemic is renewing concerns about gain-of-function research. Who's Getting the Patents? A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.